Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charlie Hospital Semarang Tbk. (RSCH) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance

Charlie Hospital Semarang Tbk.Trade
Zyrexindo Mandiri Buana Tbk.Trade

Price performance (Past 24H)

Key statistics

Charlie Hospital Semarang Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp312 (market cap 821.5B, 25.59M 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 178.67B, 949.3K 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 4.6× Zyrexindo Mandiri Buana Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.59M versus 949.3K). Which is the better fit depends on your goals.

RSCHZYRX
Market Cap
821.5B178.67B
Volume
25.59M949.3K
Lot
255.95K9.49K
Turnover
7.95B122.87M
Average Price
310.77129.43
Value
7.95B122.87M
Indicative Equilibrium Price
312129
Indicative Equilibrium Volume
1048

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RSCH
View details
ZYRX
View details

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH

About Zyrexindo Mandiri Buana Tbk.

PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik

Read more on ZYRX